# TEVJF (Teva Pharmaceutical Industries Limited) - SEC EDGAR Financial Statements

> Teva Pharmaceutical Industries Limited reported $14.02B in revenue and net income of $506.0M for the trailing twelve months ended September 30, 2026 (down 1.9% year over year), with a 65.8% gross margin and a 10.2% operating margin.

- Canonical: https://convexityos.com/fundamentals/TEVJF
- Markdown: https://convexityos.com/fundamentals/TEVJF.md
- SEC CIK: 0000818686
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:03 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000818686&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $14.02B | -1.9% YoY |
| Operating Income | TTM | $1.44B | 10.2% margin |
| Net Income | TTM | $506.0M | 3.6% net margin |
| Diluted EPS | TTM | $0.43 | Split-adjusted |
| Free Cash Flow | TTM | $1.24B | 8.8% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $4.08B | Total debt: $4.30B |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $17.26B | $16.54B | $15.85B | $14.93B | $15.88B | $16.66B | $16.89B | $18.27B | $21.85B | $21.90B |
| Cost of Revenue | $8.32B | $8.48B | $8.20B | $7.95B | $8.28B | $8.93B | $9.35B | $9.97B | $11.24B | $10.25B |
| **Gross Profit** | $8.94B | $8.06B | $7.64B | $6.97B | $7.59B | $7.73B | $7.54B | $8.30B | $10.62B | $11.65B |
| Research & Development | $1.01B | $998.0M | $953.0M | $98.00M | $967.0M | $997.0M | $1.01B | $114.0M | $175.0M | $422.0M |
| Selling, General & Admin | $3.97B | $3.70B | $3.50B | $3.44B | $3.53B | $3.67B | $3.81B | $4.21B | $4.85B | $4.97B |
| **Operating Income** | $2.16B | -$303.0M | $433.0M | -$2.20B | $1.72B | -$3.57B | -$443.0M | -$1.64B | -$17.48B | $2.15B |
| **EBITDA** | $3.16B | $756.0M | $1.59B | -$889.0M | $3.05B | -$2.02B | $1.28B | $205.0M | -$15.37B | $3.68B |
| Interest Expense | $916.0M | $1.00B | $1.03B | $930.0M | $891.0M | $901.0M | $822.0M | $920.0M | $875.0M | $546.0M |
| Income Before Tax | $1.22B | -$1.28B | -$624.0M | -$3.16B | $658.0M | -$4.41B | -$1.26B | -$2.60B | -$18.38B | $824.0M |
| Income Tax Expense | -$180.0M | $676.0M | -$7.00M | -$643.0M | $211.0M | -$168.0M | -$278.0M | -$195.0M | -$1.93B | $521.0M |
| **Net Income** | $1.41B | -$1.64B | -$559.0M | -$2.45B | $417.0M | -$3.99B | -$999.0M | -$2.15B | -$16.27B | $329.0M |
| Basic EPS | $1.23 | -$1.45 | -$0.50 | -$2.20 | $0.38 | -$3.64 | -$0.91 | -$2.35 | -$16.26 | $0.07 |
| **Diluted EPS** | $1.21 | -$1.45 | -$0.50 | -$2.20 | $0.38 | -$3.64 | -$0.91 | -$2.35 | -$16.26 | $0.07 |
| Basic Shares Outstanding | 1.15B | 1.13B | 1.12B | 1.11B | 1.10B | 1.09B | 1.09B | 1.02B | 1.02B | 955 |
| Diluted Shares Outstanding | 1.16B | 1.13B | 1.12B | 1.11B | 1.11B | 1.09B | 1.09B | 1.02B | 1.02B | 961 |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $4.39B | $4.14B | $3.98B | $1.50B | $4.48B | $4.18B | $3.89B | $4.23B |
| Cost of Revenue | $1.96B | $1.99B | $2.01B | $2.06B | $2.18B | $2.07B | $2.01B | $2.11B |
| **Gross Profit** | $2.44B | $2.15B | $1.97B | $2.66B | $2.30B | $2.10B | $1.88B | $2.12B |
| Research & Development | $297.0M | $970.0M | $222.0M | $267.0M | $256.0M | $244.0M | $247.0M | $247.0M |
| Selling, General & Admin | $1.01B | $1.03B | $1.00B | $1.12B | $973.0M | $959.0M | $919.0M | $952.0M |
| **Operating Income** | $714.0M | -$231.0M | $652.0M | $300.0M | $882.0M | $455.0M | $519.0M | -$29.00M |
| **EBITDA** | $959.0M | $10.00M | $891.0M | $560.0M | $1.13B | $706.0M | $763.0M | $240.0M |
| Income Before Tax | $300.0M | -$455.0M | $437.0M | $80.00M | $646.0M | $203.0M | $294.0M | -$247.0M |
| Income Tax Expense | $66.00M | $121.0M | $67.00M | -$390.0M | $214.0M | -$78.00M | $74.00M | $28.00M |
| **Net Income** | $233.0M | -$576.0M | $369.0M | $480.0M | $433.0M | $282.0M | $214.0M | -$217.0M |
| Basic EPS | $0.20 | -$0.49 | $0.32 | -- | $0.38 | $0.25 | $0.19 | -- |
| **Diluted EPS** | $0.20 | -$0.49 | $0.31 | -- | $0.37 | $0.24 | $0.18 | -- |
| Basic Shares Outstanding | 1.17B | 1.17B | 1.16B | -- | 1.15B | 1.15B | 1.14B | -- |
| Diluted Shares Outstanding | 1.18B | 1.17B | 1.18B | -- | 1.16B | 1.16B | 1.16B | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2023 | FY 2023 | FY 2023 | FY 2022 | FY 2022 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $3.56B | $3.30B | $3.23B | $2.25B | $2.67B | $2.14B | $2.80B | $2.23B | $2.06B | $2.17B |
| **Cash & Short-Term Investments** | $3.56B | $3.30B | $3.23B | $2.25B | $2.67B | $2.14B | $2.80B | $2.23B | $2.06B | $2.17B |
| Accounts Receivable, Net | $3.71B | $3.06B | $3.41B | $3.38B | $3.54B | $3.44B | $3.70B | $3.73B | $4.47B | $4.53B |
| Inventory | $3.18B | $3.01B | $4.02B | $4.05B | $4.11B | $4.12B | $3.83B | $3.86B | $4.05B | $3.82B |
| Other Current Assets | $539.0M | $409.0M | $504.0M | $520.0M | $486.0M | $542.0M | $549.0M | $579.0M | $518.0M | $965.0M |
| **Total Current Assets** | $13.95B | $12.55B | $12.48B | $11.43B | $12.09B | $11.50B | $12.05B | $11.45B | $12.16B | $12.57B |
| Property, Plant & Equipment, Net | $4.08B | $4.58B | $5.75B | $5.62B | $5.71B | $5.75B | $5.74B | $5.57B | $5.74B | $5.98B |
| Goodwill | $16.00B | $16.00B | $17.18B | $16.89B | $17.12B | $17.80B | $17.18B | $18.43B | $18.84B | $17.63B |
| Intangible Assets | $3.78B | $4.42B | $5.39B | $5.53B | $5.74B | $5.96B | $6.27B | $6.39B | $6.70B | $7.47B |
| Other Non-Current Assets | $405.0M | $462.0M | $470.0M | $477.0M | $443.0M | $450.0M | $441.0M | $438.0M | $454.0M | $515.0M |
| **Total Non-Current Assets** | $26.80B | $26.77B | $30.99B | $30.67B | $31.01B | $31.96B | $31.96B | $32.80B | $33.77B | $35.09B |
| **Total Assets** | $40.75B | $39.33B | $43.48B | $42.09B | $43.10B | $43.46B | $44.01B | $44.25B | $45.93B | $47.67B |
| Accounts Payable | $225.0M | $158.0M | $108.0M | $2.28B | $2.51B | $2.38B | $1.89B | $1.64B | $1.90B | $1.69B |
| Short-Term Debt | $1.82B | $1.78B | $1.67B | $1.48B | $1.98B | $1.02B | $2.11B | $2.77B | $1.72B | $1.43B |
| Other Current Liabilities | $1.18B | $1.02B | $1.04B | $1.01B | $973.0M | $1.00B | $1.00B | $945.0M | $916.0M | $903.0M |
| **Total Current Liabilities** | $13.46B | $12.80B | $12.25B | $11.39B | $11.84B | $10.41B | $11.47B | $11.53B | $11.00B | $11.03B |
| Other Non-Current Liabilities | $3.81B | $4.03B | $4.02B | $3.95B | $4.09B | $3.98B | $3.94B | $3.86B | $3.86B | $2.58B |
| **Total Non-Current Liabilities** | $19.38B | $20.81B | $23.11B | $23.31B | $23.66B | $24.55B | $23.94B | $23.21B | $25.12B | $25.39B |
| **Total Liabilities** | $32.83B | $33.61B | $35.35B | $34.71B | $35.51B | $34.96B | $35.41B | $34.75B | $36.12B | $36.42B |
| **Total Debt (incl. Leases)** | $2.25B | $2.19B | $2.12B | $1.80B | $2.32B | $1.37B | $2.57B | $3.12B | $2.09B | $1.98B |
| Common Stock | $58.00M | $58.00M | $57.00M | $57.00M | $57.00M | $57.00M | $57.00M | $57.00M | $57.00M | $57.00M |
| Retained Earnings | -$13.76B | -$15.17B | -$13.53B | -$13.99B | -$14.07B | -$13.19B | -$12.97B | -$11.67B | -$11.73B | -$10.53B |
| Accumulated Other Comp. Income | -$2.39B | -$3.15B | -$2.70B | -$2.91B | -$2.68B | -$2.70B | -$2.84B | -$3.15B | -$2.80B | -$2.68B |
| **Total Stockholders' Equity** | $7.91B | $5.37B | $7.51B | $6.93B | $7.05B | $7.86B | $7.80B | $8.77B | $9.04B | $10.28B |
| Total Equity | $7.91B | $5.38B | $8.13B | $7.39B | $7.59B | $8.50B | $8.60B | $9.51B | $9.81B | $11.24B |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $4.08B | $3.65B | $3.74B | $3.56B | $2.20B | $2.16B | $1.70B | $3.30B |
| **Cash & Short-Term Investments** | $4.08B | $3.65B | $3.74B | $3.56B | $2.20B | $2.16B | $1.70B | $3.30B |
| Accounts Receivable, Net | $3.84B | $3.49B | $3.39B | $3.71B | $3.81B | $3.56B | $3.38B | $3.06B |
| Inventory | $3.17B | $3.22B | $3.18B | $3.18B | $3.32B | $3.50B | $3.25B | $3.01B |
| Other Current Assets | $658.0M | $563.0M | $535.0M | $539.0M | $477.0M | $472.0M | $368.0M | $409.0M |
| **Total Current Assets** | $14.60B | $13.76B | $13.71B | $13.95B | $12.74B | $12.62B | $11.53B | $12.55B |
| Property, Plant & Equipment, Net | $3.75B | $3.93B | $4.00B | $4.08B | $4.82B | $4.81B | $4.63B | $4.58B |
| Goodwill | $15.74B | $15.84B | $15.82B | $16.00B | $15.95B | $15.95B | $15.48B | $16.00B |
| Intangible Assets | $3.30B | $3.45B | $3.61B | $3.78B | $3.94B | $4.14B | $4.19B | $4.42B |
| Other Non-Current Assets | $269.0M | $387.0M | $377.0M | $405.0M | $444.0M | $470.0M | $464.0M | $462.0M |
| **Total Non-Current Assets** | $25.44B | $26.10B | $26.33B | $26.80B | $27.12B | $27.51B | $26.89B | $26.77B |
| **Total Assets** | $40.04B | $39.86B | $40.04B | $40.75B | $39.86B | $40.13B | $38.41B | $39.33B |
| Accounts Payable | $2.55B | $2.72B | $2.60B | $225.0M | $2.35B | $2.50B | $2.29B | $158.0M |
| Short-Term Debt | $4.04B | $4.50B | $2.61B | $1.82B | $24.00M | $464.0M | $421.0M | $1.78B |
| Other Current Liabilities | $1.04B | $987.0M | $1.11B | $1.18B | $1.10B | $940.0M | $964.0M | $1.02B |
| **Total Current Liabilities** | $15.43B | $15.65B | $13.53B | $13.46B | $11.49B | $11.86B | $11.16B | $12.80B |
| Other Non-Current Liabilities | $3.42B | $3.79B | $3.71B | $3.81B | $3.66B | $3.94B | $4.01B | $4.03B |
| **Total Non-Current Liabilities** | $16.63B | $16.45B | $18.28B | $19.38B | $21.11B | $21.44B | $20.99B | $20.81B |
| **Total Liabilities** | $32.06B | $32.10B | $31.81B | $32.83B | $32.60B | $33.30B | $32.15B | $33.61B |
| **Total Debt (incl. Leases)** | $4.30B | $4.78B | $2.89B | $2.25B | $307.0M | $760.0M | $709.0M | $2.19B |
| Common Stock | $59.00M | $59.00M | $59.00M | $58.00M | $58.00M | $58.00M | $58.00M | $58.00M |
| Retained Earnings | -$13.74B | -$13.97B | -$13.39B | -$13.76B | -$14.24B | -$14.68B | -$14.96B | -$15.17B |
| Accumulated Other Comp. Income | -$2.56B | -$2.46B | -$2.51B | -$2.39B | -$2.48B | -$2.43B | -$2.67B | -$3.15B |
| **Total Stockholders' Equity** | $7.98B | $7.75B | $8.23B | $7.91B | $7.25B | $6.83B | $6.26B | $5.37B |
| Total Equity | $7.98B | $7.76B | $8.23B | $7.91B | $7.25B | $6.83B | $6.27B | $5.38B |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $1.42B | -$1.96B | -$615.0M | -$2.50B | $456.0M | -$4.10B | -$1.00B | -$2.47B | -$16.45B | $311.0M |
| Depreciation & Amortization | $1.00B | $1.06B | $1.15B | $1.31B | $1.33B | $1.56B | $1.72B | $1.84B | $2.11B | $1.52B |
| Stock-Based Compensation | $157.0M | $123.0M | $121.0M | $124.0M | $119.0M | $129.0M | $119.0M | $155.0M | $133.0M | $124.0M |
| Change in Working Capital | -$1.37B | -$435.0M | -$72.00M | $1.35B | -$1.70B | -$2.19B | -$896.0M | -$1.82B | -$1.65B | -$116.0M |
| Change in Inventory | -$152.0M | -$166.0M | $147.0M | $163.0M | -$380.0M | -$41.00M | -$271.0M | -$26.00M | -$199.0M | -$370.0M |
| **Operating Cash Flow** | $1.65B | $1.25B | $1.37B | $1.59B | $798.0M | $1.22B | $748.0M | $2.45B | $2.23B | $3.89B |
| Capital Expenditure | -$501.0M | -$498.0M | -$526.0M | -$548.0M | -$562.0M | -$578.0M | -$525.0M | -$651.0M | -$874.0M | -$901.0M |
| **Free Cash Flow** | $1.15B | $749.0M | $842.0M | $1.04B | $236.0M | $638.0M | $223.0M | $1.79B | $1.35B | $2.99B |
| Acquisitions, Net | $0 | -$15.00M | $0 | -$7.00M | $0 | $0 | -- | -- | $43.00M | -$36.15B |
| Sales & Maturities of Investments | $42.00M | $40.00M | $0 | $4.00M | $172.0M | $12.00M | $2.00M | -- | -- | -- |
| **Investing Cash Flow** | $737.0M | $792.0M | $968.0M | $656.0M | $1.52B | $863.0M | $1.35B | $1.87B | $3.45B | -$34.41B |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | -- | $0 | $329.0M |
| Share Repurchases | -- | -- | -- | -- | -- | -- | -- | -- | $0 | $0 |
| Dividends Paid | -- | -- | -- | -- | -- | -- | -- | -$12.00M | -$901.0M | -$1.30B |
| **Financing Cash Flow** | -$2.15B | -$1.79B | -$1.91B | -$1.49B | -$2.17B | -$1.89B | -$1.93B | -$3.35B | -$5.75B | $25.22B |
| **Net Change in Cash** | $256.0M | $74.00M | $393.0M | $636.0M | $21.00M | $202.0M | $193.0M | $819.0M | -$25.00M | -$5.96B |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $234.0M | -$575.0M | $369.0M | $481.0M | $434.0M | $283.0M | $220.0M | -$275.0M |
| Depreciation & Amortization | $245.0M | $241.0M | $239.0M | $260.0M | $249.0M | $251.0M | $244.0M | $269.0M |
| Stock-Based Compensation | $38.00M | $40.00M | $43.00M | $51.00M | $34.00M | $38.00M | $34.00M | $34.00M |
| Change in Working Capital | -$682.0M | -$164.0M | -$617.0M | $281.0M | -$578.0M | -$336.0M | -$700.0M | -$245.0M |
| Change in Inventory | -$29.00M | $59.00M | $93.00M | -$136.0M | $165.0M | $61.00M | $120.0M | -- |
| **Operating Cash Flow** | $241.0M | $411.0M | -$40.00M | $1.16B | $369.0M | $227.0M | -$105.0M | $575.0M |
| Capital Expenditure | -$120.0M | -$104.0M | -$168.0M | -$142.0M | -$136.0M | -$96.00M | -$127.0M | -$129.0M |
| **Free Cash Flow** | $121.0M | $307.0M | -$208.0M | $1.02B | $233.0M | $131.0M | -$232.0M | $446.0M |
| Acquisitions, Net | -- | -- | -- | $0 | $0 | $0 | $0 | $0 |
| Sales & Maturities of Investments | -- | -- | -- | -- | $0 | -- | -- | -- |
| **Investing Cash Flow** | $210.0M | -$491.0M | $229.0M | $165.0M | $135.0M | $236.0M | $201.0M | $202.0M |
| **Financing Cash Flow** | $6.00M | -$1.00M | $13.00M | $40.00M | -$453.0M | $6.00M | -$1.74B | -$674.0M |
| **Net Change in Cash** | $430.0M | -$86.00M | $185.0M | $1.35B | $42.00M | $464.0M | -$1.60B | -$18.00M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 51.8% | 48.7% | 48.2% | 46.7% | 47.8% | 46.4% | 44.6% | 45.4% | 48.6% | 53.2% |
| **Operating Margin** | 12.5% | -1.8% | 2.7% | -14.7% | 10.8% | -21.4% | -2.6% | -9.0% | -80.0% | 9.8% |
| **Net Profit Margin** | 8.2% | -9.9% | -3.5% | -16.4% | 2.6% | -24.0% | -5.9% | -11.8% | -74.4% | 1.5% |
| Return on Equity (ROE) | 17.8% | -30.5% | -7.4% | -31.3% | 4.1% | -39.8% | -7.2% | -14.6% | -93.7% | 1.0% |
| Return on Assets (ROA) | 3.5% | -4.2% | -1.3% | -5.6% | 0.9% | -7.9% | -1.7% | -3.5% | -23.0% | 0.4% |
| Current Ratio | 1.04x | 0.98x | 1.02x | 1.05x | 1.14x | 0.99x | 0.98x | 0.96x | 0.86x | 0.93x |
| Quick Ratio | 0.80x | 0.75x | 0.69x | 0.72x | 0.79x | 0.65x | 0.66x | 0.63x | 0.58x | 0.66x |
| Debt to Equity | 0.28x | 0.41x | 0.28x | 0.33x | 0.19x | 0.38x | 0.21x | 0.15x | 1.70x | 1.05x |
| **Revenue Growth (YoY)** | +4.3% | +4.4% | +6.2% | -6.0% | -4.7% | -1.4% | -7.6% | -16.4% | -0.2% | +11.5% |
| Gross Profit Growth (YoY) | +10.8% | +5.5% | +9.6% | -8.2% | -1.7% | +2.5% | -9.1% | -21.8% | -8.9% | +2.6% |
| Operating Income Growth (YoY) | -- | -170.0% | -- | -228.0% | -- | -- | -- | -- | -911.7% | -35.7% |
| **Net Income Growth (YoY)** | -- | -- | -- | -686.6% | -- | -- | -- | -- | -5043.8% | -79.3% |
| EPS Growth (YoY) | -- | -- | -- | -678.9% | -- | -- | -- | -- | -23328.6% | -96.2% |
| Operating Cash Flow Growth (YoY) | +32.2% | -8.8% | -14.0% | +99.2% | -34.4% | +62.6% | -69.4% | +9.9% | -42.8% | -29.8% |
| Free Cash Flow Growth (YoY) | +53.3% | -11.0% | -19.2% | +341.5% | -63.0% | +186.1% | -87.6% | +32.9% | -54.8% | -37.3% |
| 5Y Revenue / Share Growth | -0.9% | -5.5% | -20.9% | -37.5% | -100.0% | -33.8% | -34.9% | -25.2% | -7.7% | +111468990.7% |
| 10Y Revenue / Share Growth | -34.4% | -38.4% | -40.8% | -42.3% | -30.0% | -15.4% | -16.3% | +25.9% | +75.6% | -- |
| 5Y Net Income / Share Growth | -- | -- | -- | -- | -100.0% | -296.2% | -125.6% | -240.9% | -811.1% | +11112887.7% |
| 10Y Net Income / Share Growth | -33.7% | -140.5% | -133.4% | -197.9% | -87.8% | -198.0% | -139.9% | -369.7% | -742.4% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 65.8% | 64.4% | 63.9% | 63.6% | 50.1% | 49.6% | 49.2% | 48.7% |
| **Operating Margin** | 10.2% | 11.4% | 16.2% | 15.3% | 10.9% | 5.4% | 2.6% | -1.8% |
| **Net Profit Margin** | 3.6% | 5.0% | 11.1% | 10.0% | 4.2% | -1.0% | -7.7% | -9.9% |
| Return on Equity (ROE) | 6.3% | 9.1% | 19.0% | 17.8% | 9.8% | -2.3% | -20.5% | -30.5% |
| Return on Assets (ROA) | 1.3% | 1.8% | 3.9% | 3.5% | 1.8% | -0.4% | -3.3% | -4.2% |
| Current Ratio | 0.95x | 0.88x | 1.01x | 1.04x | 1.11x | 1.06x | 1.03x | 0.98x |
| Quick Ratio | 0.74x | 0.67x | 0.78x | 0.80x | 0.82x | 0.77x | 0.74x | 0.75x |
| Debt to Equity | 0.54x | 0.62x | 0.35x | 0.28x | 0.04x | 0.11x | 0.11x | 0.41x |
| **Revenue Growth (YoY)** | -1.9% | -0.8% | +2.3% | -64.5% | +3.4% | +0.3% | +1.9% | -5.1% |
| Gross Profit Growth (YoY) | +5.9% | +2.4% | +5.1% | +25.2% | +7.3% | +3.9% | +6.0% | -12.2% |
| Operating Income Growth (YoY) | -19.0% | -150.8% | +25.6% | -- | -- | -- | -- | -103.8% |
| **Net Income Growth (YoY)** | -46.2% | -304.3% | +72.4% | -- | -- | -- | -- | -146.9% |
| EPS Growth (YoY) | -47.4% | -296.0% | +68.4% | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -34.7% | +81.1% | -- | +101.4% | -46.8% | +120.4% | -- | -51.4% |
| Free Cash Flow Growth (YoY) | -48.1% | +134.4% | -- | +127.8% | -57.2% | +2083.3% | -- | -58.1% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
